Published in Am J Physiol Gastrointest Liver Physiol on March 25, 2010
Dextran sodium sulphate colitis mouse model: traps and tricks. J Biomed Biotechnol (2012) 2.97
Interactions between coagulation and complement--their role in inflammation. Semin Immunopathol (2011) 1.46
Complement activation promotes colitis-associated carcinogenesis through activating intestinal IL-1β/IL-17A axis. Mucosal Immunol (2015) 0.93
Complement-dependent injury and protection in a murine model of acute dextran sulfate sodium-induced colitis. J Immunol (2012) 0.86
Contact pathway of coagulation and inflammation. Thromb J (2015) 0.81
Regulation of the alternative pathway of complement modulates injury and immunity in a chronic model of dextran sulphate sodium-induced colitis. Clin Exp Immunol (2015) 0.79
A novel protocol allowing oral delivery of a protein complement inhibitor that subsequently targets to inflamed colon mucosa and ameliorates murine colitis. Clin Exp Immunol (2014) 0.76
Orally administered extract from Prunella vulgaris attenuates spontaneous colitis in mdr1a(-/-) mice. World J Gastrointest Pharmacol Ther (2015) 0.75
Atypical Hemolytic Uremic Syndrome and Chronic Ulcerative Colitis Treated with Eculizumab. Int J Med Pharm Case Reports (2015) 0.75
Factor XII-Driven Inflammatory Reactions with Implications for Anaphylaxis. Front Immunol (2017) 0.75
SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med (2011) 11.07
Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell (2013) 9.24
Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol (2004) 3.07
Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor. J Clin Invest (2002) 1.82
LNA-mediated anti-miR-155 silencing in low-grade B-cell lymphomas. Blood (2012) 1.42
Integrative genomic analysis implicates gain of PIK3CA at 3q26 and MYC at 8q24 in chronic lymphocytic leukemia. Clin Cancer Res (2012) 1.33
Complement regulatory protein C1 inhibitor binds to selectins and interferes with endothelial-leukocyte adhesion. J Immunol (2003) 1.09
A direct role for C1 inhibitor in regulation of leukocyte adhesion. J Immunol (2005) 0.98
Deficiencies of C1 inhibitor. Best Pract Res Clin Gastroenterol (2005) 0.93
C1 inhibitor prevents endotoxin shock via a direct interaction with lipopolysaccharide. J Immunol (2003) 0.91
C1 inhibitor prevents Gram-negative bacterial lipopolysaccharide-induced vascular permeability. Blood (2004) 0.90
C1 inhibitor-mediated protection from sepsis. J Immunol (2007) 0.88
The effect of C1 inhibitor on myocardial ischemia and reperfusion injury. Cardiovasc Pathol (2012) 0.85
Nuclear phosphatases and the proteasome in suppression of STAT1 activity in hepatocytes. Biochem Biophys Res Commun (2002) 0.84
N-linked glycosylation is required for c1 inhibitor-mediated protection from endotoxin shock in mice. Infect Immun (2004) 0.83
Estrogen-dependent inherited angioedema. Transfus Apher Sci (2003) 0.83
The effect of C1 inhibitor on intestinal ischemia and reperfusion injury. Am J Physiol Gastrointest Liver Physiol (2008) 0.83
C1 inhibitor suppresses the endotoxic activity of a wide range of lipopolysaccharides and interacts with live gram-negative bacteria. Shock (2012) 0.77
A phase I study of escalated dose subcutaneous alemtuzumab given weekly with rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma. Haematologica (2013) 0.76
Approaches toward reversal of increased vascular permeability in C1 inhibitor deficient mice. Immunol Lett (2003) 0.75
Normal transcription of the C1 inhibitor gene is dependent upon a polypurine-polypyrimidine region within the promoter. Inflammation (2002) 0.75